Our top pick for
Revlon, Inc is a household & personal products business based in the US. Revlon shares (REV) are listed on the NYSE and all prices are listed in US Dollars. Revlon employs 7,100 staff and has a trailing 12-month revenue of around USD$2 billion.
|52-week range||USD$3.96 - USD$19|
|50-day moving average||USD$11.5939|
|200-day moving average||USD$9.3506|
|Wall St. target price||USD$13|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-4.16|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Revlon stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Revlon's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Revlon's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$90.9 million.
The EBITDA is a measure of a Revlon's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$2 billion|
|Operating margin TTM||1.17%|
|Gross profit TTM||USD$1.4 billion|
|Return on assets TTM||0.48%|
|Return on equity TTM||0%|
|Market capitalisation||USD$623.5 million|
TTM: trailing 12 months
There are currently 1.9 million Revlon shares held short by investors – that's known as Revlon's "short interest". This figure is 6% down from 2.1 million last month.
There are a few different ways that this level of interest in shorting Revlon shares can be evaluated.
Revlon's "short interest ratio" (SIR) is the quantity of Revlon shares currently shorted divided by the average quantity of Revlon shares traded daily (recently around 539257.77777778). Revlon's SIR currently stands at 3.6. In other words for every 100,000 Revlon shares traded daily on the market, roughly 3600 shares are currently held short.
However Revlon's short interest can also be evaluated against the total number of Revlon shares, or, against the total number of tradable Revlon shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Revlon's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Revlon shares in existence, roughly 40 shares are currently held short) or 0.2795% of the tradable shares (for every 100,000 tradable Revlon shares, roughly 280 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Revlon.
Find out more about how you can short Revlon stock.
We're not expecting Revlon to pay a dividend over the next 12 months.
Revlon's shares were split on a 1:10 basis on 16 September 2008. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Revlon shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Revlon shares which in turn could have impacted Revlon's share price.
Over the last 12 months, Revlon's shares have ranged in value from as little as $3.96 up to $19. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Revlon's is 2.8687. This would suggest that Revlon's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Revlon, Inc., through its subsidiaries, develops, manufactures, markets, distributes, and sells beauty and personal care products worldwide. The company's Relvon segment offers color cosmetics and beauty tools under the Revlon brand; and hair color under the Revlon ColorSilk and Revlon Professional brands. Its Elizabeth Arden segment markets, distributes and sells skin care products under the Elizabeth Arden Ceramide, Prevage, Eight Hour, SUPERSTART, Visible Difference, and Skin Illuminating brands; and fragrances under the Elizabeth Arden White Tea, Elizabeth Arden Red Door, Elizabeth Arden 5th Avenue, and Elizabeth Arden Green Tea brands. The company's Portfolio segment offers color cosmetics under the Almay and SinfulColors brands; men's grooming products under the American Crew brand; nail polishes, gel nail color, and nail enhancements under the CND brand; nail care products under the Cutex brand; anti-perspirant deodorants under the Mitchum brand; hair care products under the Creme of Nature; and hair color line under the Llongueras brand. Its Fragrances segment develops, markets, and distributes owned and licensed fragrances, as well as distributes prestige fragrance brands owned by third parties. This segment offers its products under the Juicy Couture, John Varvatos, AllSaints, Britney Spears, Elizabeth Taylor, Christina Aguilera, Jennifer Aniston, Mariah Carey, Curve, Giorgio Beverly Hills, Ed Hardy, Charlie, Lucky Brand, ?PS?, Alfred Sung, Halston, Geoffrey Beene, and White Diamonds brands. The company sells its products through sales force, sales representatives, and independent distributors, as well as licenses its Revlon, The Elizabeth Arden, and Red Door trademarks to the manufacturers of complementary beauty-related products and accessories. Revlon, Inc. was founded in 1932 and is based in New York, New York.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
Everything we know about the ChargePoint IPO, plus information on how to buy in.
Everything we know about the Kaltura Inc IPO, plus information on how to buy in.
Everything we know about the Rocket Lab IPO, plus information on how to buy in.
Everything we know about the Soho House IPO, plus information on how to buy in.
Everything we know about the VIZIO IPO, plus information on how to buy in.
Everything we know about the IDW Media Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Karooooo Ltd IPO, plus information on how to buy in.
Everything we know about the Connect Biopharma Holdings Limited IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.